Prospective, observational study published in CardioVascular and Interventional Radiology 1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a
Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Merit Medical's (MMSI) new commercial product launch can make sample collection simple, safe and efficient.
Advanced design makes sample collection simple, efficient, and safe Advanced design makes sample collection simple, efficient, and safe
Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2021 Results - Earnings Call Transcript
Merit Medical (MMSI) delivered earnings and revenue surprises of 40.91% and 11.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
* Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are no
Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.
SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnost
These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
Investors continue to be optimistic about Merit Medical (MMSI), owing to its potential in the Peripheral Intervention arm and strong international foothold.
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2021 Results - Earnings Call Transcript
Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q1.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE